|
|
|
Volumn 7, Issue 18 SUPP., 2001, Pages
|
|
Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DESOGESTREL;
ESTRANE DERIVATIVE;
ETHINYLESTRADIOL;
ETYNODIOL DIACETATE;
GESTAGEN;
GESTODENE;
GONANE DERIVATIVE;
HORMONE;
HYDROXYPROGESTERONE ACETATE;
LEVONORGESTREL;
LYNESTRENOL;
MEDROXYPROGESTERONE ACETATE;
MEGESTROL ACETATE;
NANDROLONE DERIVATIVE;
NORELGESTROMIN;
NORETHISTERONE;
NORETHISTERONE ACETATE;
NORETYNODREL;
NORGESTIMATE;
NORGESTREL;
ORAL CONTRACEPTIVE AGENT;
PREGNANE DERIVATIVE;
UNCLASSIFIED DRUG;
BIOMEDICAL ENGINEERING;
BREAKTHROUGH BLEEDING;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTRACEPTION;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG BINDING;
DRUG DELIVERY SYSTEM;
DRUG HALF LIFE;
DRUG INHIBITION;
DRUG MARKETING;
DRUG POTENCY;
ECONOMIC EVALUATION;
HORMONE SUBSTITUTION;
HUMAN;
OUTCOMES RESEARCH;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SIDE EFFECT;
STRUCTURE ANALYSIS;
TRANSDERMAL PATCH;
ADMINISTRATION, CUTANEOUS;
CONTRACEPTIVES, ORAL, HORMONAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HORMONE REPLACEMENT THERAPY;
HUMANS;
PROGESTINS;
UNITED STATES;
|
|
EID: 0035203123
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (13)
|
